Use of rotigotine for treating and preventing Parkinson's plus syndrome
US7872041B2 · kind B2 · utility
10Cited by
32References
31Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 22, 2005 |
| Grant date | Jan 18, 2011 |
| Priority date | — |
| Expiry date | Jun 2, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of rotigotine, its salts and prodrugs, as a medicament for preventing and/or treating Parkinson's plus syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.